x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DCL-001243
| Product Information | |
|---|---|
| Organism | Mouse |
| Tissue | Pancreas |
| Cell Type | Islet beta cells |
| Phenotype | Insulinoma |
| Product Description | This cell line was derived from an insulinoma arising in a double-transgenic mouse expressing the SV40 T antigen oncogene in pancreatic β cells under the tet-off system. |
| Format | Frozen |
| Growth Properties | Adherent |
| Shipping & Storage | |
|---|---|
| Shipping | Cryopreserved on dry ice. |
| Storage Instructions | 37 °C, 95% Air, 5% CO2. Store in vapor phase of liquid nitrogen. |
| Storage Buffer/Media | DMEM containing 25 mM glucose and supplemented with 15% heat-inactivated horse serum (Gibco) and 2.5% fetal bovine serum. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
